NEOVASC INC (NVCN) Stock News
NASDAQ:NVCN - Nasdaq - CA64065J4037 - Common Stock - Currency: USD
NVCN Latest News, Press Relases and Analysis
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today...
Mentions: NVCN.CA
Neovasc Shareholders Approve Acquisition by Shockwave Medical
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the...
Mentions: NVCN.CA
Why Neovasc Shares Are Trading Higher Today
Neovasc Inc. (NASDAQ: NVCN) shares are trading higher after ShockWave Medical, Inc. (NASDAQ: SWAV) announced it would acquire the company.
Mentions: SWAV
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.
Mentions: SWAV
Neovasc Announces German Reimbursement Renewal
VANCOUVER and MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (“Neovasc” or “the Company”) (NASDAQ , TSX : NVCN) today...
Mentions: NVCN.CA
SWAV stock defended at BofA; says Neovasc “not a big risk” (NASDAQ:SWAV)
Bank of America reaffirmed its Buy rating on ShockWave Medical (SWAV) after its shares witnessed a sharp in reaction to a deal to acquire Neovasc (NVCN). Read the full story here.
Neovasc stock soars ~30% as Shockwave set to acquire it in ~$100M deal
Shockwave Medical (SWAV) is acquiring Neovasc (NVCN) for an enterprise value of ~$100M.Canada-based medical device maker Neovasc is developing a minimally invasive treatment for...
Mentions: SWAV
Shockwave Medical to Acquire Neovasc
VANCOUVER, BC, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN), a leader in the...
Mentions: NVCN.CA
Neovasc Announces Progress on COSIRA-II Clinical Trial
VANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today...
Mentions: NVCN.CA
Neovasc Comments on European Heart Journal Publication
VANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today...
Mentions: NVCN.CA
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
VANCOUVER and MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today...
Mentions: NVCN.CA
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
VANCOUVER and MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today...
Mentions: NVCN.CA
Neovasc to Report Third Quarter Financial Results on November 10, 2022
VANCOUVER and MINNEAPOLIS, Oct. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ , TSX : NVCN) will report financial results for...
Mentions: NVCN.CA
Neovasc Provides Corporate Update Following Clinical Data Release
New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease VANCOUVER and MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- via...
Mentions: NVCN.CA
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit
VANCOUVER and MINNEAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today...
Mentions: NVCN.CA